A detailed history of Fsb Premier Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Fsb Premier Wealth Management, Inc. holds 1,886 shares of ABBV stock, worth $339,480. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,886
Previous 1,770 6.55%
Holding current value
$339,480
Previous $303,000 22.77%
% of portfolio
0.16%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $19,005 - $23,122
116 Added 6.55%
1,886 $372,000
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $773 - $903
5 Added 0.28%
1,770 $303,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $799 - $910
5 Added 0.28%
1,765 $321,000
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $550 - $619
4 Added 0.23%
1,760 $272,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $667 - $773
5 Added 0.29%
1,756 $261,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $1,060 - $1,319
8 Added 0.46%
1,751 $235,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $8,965 - $10,325
62 Added 3.69%
1,743 $277,000
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $553 - $663
4 Added 0.24%
1,681 $271,000
Q3 2022

Nov 23, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.18%
1,677 $225,000
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $18,716 - $23,794
-136 Reduced 7.51%
1,674 $256,000
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $4,619 - $5,731
35 Added 1.97%
1,810 $293,000
Q4 2021

Feb 03, 2022

BUY
$107.43 - $135.93 $190,688 - $241,275
1,775 New
1,775 $240,000
Q3 2021

Feb 23, 2022

SELL
$106.4 - $120.78 $212,480 - $241,197
-1,997 Closed
0 $0
Q2 2021

Feb 22, 2022

BUY
$105.21 - $117.21 $420 - $468
4 Added 0.2%
1,997 $225,000
Q1 2021

Feb 22, 2022

SELL
$102.3 - $112.62 $62,812 - $69,148
-614 Reduced 23.55%
1,993 $215,000
Q4 2020

Feb 16, 2022

BUY
$80.49 - $108.67 $209,837 - $283,302
2,607 New
2,607 $279,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fsb Premier Wealth Management, Inc. Portfolio

Follow Fsb Premier Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fsb Premier Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fsb Premier Wealth Management, Inc. with notifications on news.